ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹124 Cr | ₹165 Cr | ₹222 Cr | ₹442 Cr | ₹519 Cr |
What is the latest Total Non-Current Liabilities ratio of ORCHID PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹124 Cr |
Mar2023 | ₹165 Cr |
Mar2022 | ₹222 Cr |
Mar2021 | ₹442 Cr |
Mar2020 | ₹519 Cr |
How is Total Non-Current Liabilities of ORCHID PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹124 Cr | -24.43 | |
Mar2023 | ₹165 Cr | -25.96 | |
Mar2022 | ₹222 Cr | -49.71 | |
Mar2021 | ₹442 Cr | -14.78 | |
Mar2020 | ₹519 Cr | - |
Compare Total Non-Current Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,751.8 Cr | 1.6% | 5% | -37.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 1.6% |
5% |
-37.6% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses